Brittany Johnson PhD - What GLP-1 Drugs Really Do To Appetite, Muscle, And Long-Term Weight

GLP-1 drugs are changing the weight loss landscape fast, but the most important questions aren’t about hype, they’re about outcomes. We sit down with Dr. Brittany Johnson, a registered dietitian-nutritionist and PhD scientist, to explain what GLP-1 medications actually do in the body: appetite suppression, slower gastric emptying, and improved blood sugar control, plus why people often talk about Ozempic when they really mean a broader class of medications. We also dig into semaglutide vs tirzepatide, what “higher efficacy” really means, and why side effects and results can look different person to person. 

From an exercise and sports science lens, we go straight at body composition. How much lean mass do people risk losing during rapid weight loss, and why is it so hard to measure true muscle loss in the research? We talk through the practical basics that keep showing up in the evidence: resistance training, higher protein intake, and the potential role of creatine. Then we tackle the part too many people avoid: stopping the drug. With data suggesting many users discontinue within a year due to cost or side effects, we unpack what weight regain can look like, why fat can return faster than lean mass, and how that can set up long-term health problems if you don’t build sustainable habits. 

We also explore the human side of “food noise” reduction, including cravings, alcohol interest, motivation, and the social joy of eating. Plus: micronutrient gaps that can worsen when people eat less but not better, and why supplements may matter more in this GLP-1 era. Subscribe, share this with a friend considering GLP-1s, and leave a review with your biggest question about training and nutrition while on these medications.